The treatment for congenital cyanotic cardiac malformations with decreased pulmonary blood flow in the newborns and in the small infants chiefly consists of a systemic to pulmonary artery shunt which enables the child to survive and reach a somatic development so that a complete correction with the least risk is possible. The systemic to pulmonary artery shunt most commonly used in cardiac surgery is that of Blalock-Taussig which, also from the authors' experience, has practically no mortality risk and almost no risk of cardiac postoperative failure. However, there exist anatomic conditions and complex cyanotic cardiac malformations which render the Blalock-Taussig or Waterston shunt extremely difficult and therefore with uncertain results. In these cases the recent use of a polytetrafluoroethylene tube (Gore-Tex) for a systemic to pulmonary artery shunt has proved very useful, with good immediate and long term results. The authors report that in 17 newborns and small infants (medium weight 3.7 kg; standard deviation 1.1) they experienced a mortality rate of 29%, not due to technique employed but rather to the gravity of the cardiac malformations. Finally, the authors emphasize the present indications and future possibilities of this new surgical technique.
|Translated title of the contribution||Systemic to pulmonary artery shunts with P.T.F.E. tubes|
|Number of pages||4|
|Journal||Pediatria Medica e Chirurgica|
|Publication status||Published - 1979|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health